SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1031)2/12/1998 9:03:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Has anybody found out if Bluestone Capital has a research department?

Only a few trading sessions left until the Bluestone contract expires!



To: Rudy Saucillo who wrote (1031)2/17/1998 8:52:00 AM
From: scaram(o)uche  Read Replies (2) | Respond to of 2742
 
Galton and BlueStone:

prnewswire.com



To: Rudy Saucillo who wrote (1031)2/18/1998 4:27:00 PM
From: Steve Harmon  Respond to of 2742
 
Periodontal news very disappointing. Of course at current levels it is not in the stock price anyway. Look for a hostile takeover to take place for Cistron's cash and IL-1 patents. The battle for the roughly 10 million share float should be interesting.

At current levels CIST could buy the float for $2.5 million and still have $11 million to burn. CIST has to do something soon or the hostile buyer will get control of CIST's assets very cheaply.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News